#1 Clinical Trials Search in Europe

Mirtazapine

Mirtazapine, an antidepressant medication, has been the subject of various clinical trials exploring its potential benefits beyond its primary use in treating depression. These studies have investigated mirtazapine’s effects on conditions such as insomnia, nausea and vomiting in pregnancy, functional dyspepsia, and sleep disorders in Alzheimer’s disease. This article summarizes key findings from recent clinical trials, shedding light on the diverse applications of mirtazapine in medical research.

Table of Contents

What is Mirtazapine?

Mirtazapine is a medication primarily used to treat depression. It belongs to a class of drugs called atypical antidepressants[8]. Mirtazapine is also known by its brand names Remeron, Remergil, and Remergon[6][4][8]. This medication works differently from other antidepressants and has unique properties that make it useful for treating various conditions beyond depression.

Conditions Treated with Mirtazapine

Mirtazapine is used to treat several conditions, including:

  • Major Depressive Disorder: This is the primary use of mirtazapine. It helps improve mood, sleep, appetite, and energy levels in people with depression[4].
  • Anxiety: Some studies have explored the use of mirtazapine for anxiety disorders, particularly when they occur alongside depression[1].
  • Sleep Disorders: Mirtazapine has been studied for its effects on improving sleep in various conditions, including insomnia and sleep disorders in Alzheimer’s disease[2][5].
  • Nausea and Vomiting: Research is being conducted on the use of mirtazapine for severe nausea and vomiting during pregnancy[8].
  • Functional Dyspepsia: This is a digestive disorder characterized by stomach pain and discomfort. Mirtazapine has been studied for its potential to help with this condition[3].
  • Weight Gain in Cancer Patients: Some studies have explored the use of mirtazapine to help prevent weight loss in cancer patients undergoing treatment[7].

How Mirtazapine Works

Mirtazapine works by affecting certain chemicals in the brain called neurotransmitters. Specifically, it increases the levels of norepinephrine and serotonin, which are important for regulating mood, sleep, and appetite[8]. This mechanism of action is what gives mirtazapine its antidepressant effects.

Additionally, mirtazapine has antihistamine properties, which contribute to its sleep-promoting and appetite-stimulating effects. It also has anti-nausea properties, which is why it’s being studied for conditions involving nausea and vomiting[8].

Dosage and Administration

Mirtazapine is typically taken orally, usually once a day at bedtime. The dosage can vary depending on the condition being treated and the individual patient’s response. Some common dosages observed in clinical trials include:

  • 15 mg daily for depression and anxiety[1][3]
  • 15-45 mg daily for sleep disorders and weight gain in cancer patients[5][7]
  • 30 mg daily in some short-term studies[6]

It’s important to note that dosage should always be determined by a healthcare provider based on individual patient needs and response to the medication.

Side Effects and Considerations

Like all medications, mirtazapine can cause side effects. Some common side effects include:

  • Increased appetite and weight gain: This can be beneficial for some patients but may be undesirable for others[4].
  • Drowsiness or sedation: This is why mirtazapine is often taken at bedtime[9].
  • Dry mouth
  • Constipation
  • Dizziness

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the side effects for your specific situation.

Ongoing Research and Potential New Uses

Researchers continue to study mirtazapine for various conditions. Some areas of ongoing research include:

  • Nausea and vomiting in pregnancy: A study is exploring the use of mirtazapine for severe nausea and vomiting during pregnancy that doesn’t respond to standard treatments[8].
  • Sleep disorders in Alzheimer’s disease: Researchers are investigating whether mirtazapine can help improve sleep in people with Alzheimer’s disease[5].
  • Weight gain in cancer patients: Studies are looking at whether mirtazapine can help prevent weight loss in cancer patients undergoing treatment[7].
  • Functional dyspepsia: Research is being conducted on the use of mirtazapine for this digestive disorder[3].

These studies highlight the potential versatility of mirtazapine in treating various conditions beyond its primary use as an antidepressant. However, it’s important to remember that these are areas of research, and mirtazapine may not be approved for these uses yet. Always consult with a healthcare provider about the most appropriate treatments for your specific condition.

Condition Studied Key Findings/Objectives Dosage Duration
Depression with ICD Evaluating if mirtazapine reduces ICD shocks and improves depressive affect 15 mg daily Not specified
Chronic Insomnia Investigating safety and efficacy of esmirtazapine (Org 50081) 4.5 mg daily 52 weeks
Functional Dyspepsia Assessing efficacy in treating functional dyspepsia with weight loss 15 mg daily 8 weeks double-blind, 8 weeks open-label
Late-Life Depression Studying LEPR polymorphism and weight gain induced by mirtazapine 7.5 mg to 45 mg daily 12 weeks
Sleep Disorders in Alzheimer’s Evaluating efficacy in treating sleep disorders in Alzheimer’s disease 15 mg daily 14 days
Metabolic Effects in Healthy Subjects Determining short-term metabolic changes 30 mg daily 7 days
Weight Loss in Cancer Patients Assessing if mirtazapine can prevent weight loss in cancer patients 15 mg daily 8 weeks
Severe Nausea and Vomiting in Pregnancy Determining acceptability, dosing, tolerability, and safety for sNVP 15 mg to 45 mg daily 3 weeks, with option to continue

FAQ

  • What is mirtazapine primarily used for? Mirtazapine is primarily used as an antidepressant medication to treat depression. It belongs to the class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs).
  • What other conditions are being studied for potential mirtazapine treatment? Clinical trials have explored mirtazapine's potential in treating insomnia, severe nausea and vomiting in pregnancy, functional dyspepsia, sleep disorders in Alzheimer's disease, and weight loss in cancer patients.
  • How does mirtazapine affect sleep? Several studies have shown that mirtazapine may improve sleep parameters such as total sleep time, sleep latency (time to fall asleep), and wake time after sleep onset. It has been investigated for its potential in treating chronic insomnia and sleep disorders in Alzheimer's disease patients.
  • Are there any side effects associated with mirtazapine use? Common side effects of mirtazapine can include increased appetite, weight gain, drowsiness, and dry mouth. In clinical trials, researchers monitor for adverse events and discontinuations due to side effects to assess the drug's safety profile.
  • How is mirtazapine being studied for use in pregnancy? A clinical trial is investigating mirtazapine as a potential treatment for severe nausea and vomiting in pregnancy (sNVP) that is not responsive to standard treatments. The study aims to determine the acceptability, dosing, tolerability, and safety of mirtazapine for this condition.

Ongoing Clinical Trials on Mirtazapine

  • Study on the Effects of Mirtazapine for Improving Symptoms in Patients with Rett Syndrome

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Study on Dexamethasone for Patients with Moderate to Severe Depression: Evaluating Its Effectiveness with Mirtazapine, Citalopram, and Nortriptyline

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Mirtazapine: An antidepressant medication belonging to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs), primarily used to treat depression but also being studied for other conditions.
  • Clinical trial: A research study that tests how well new medical approaches work in people, often used to evaluate the safety and efficacy of new drugs or treatments.
  • Insomnia: A sleep disorder characterized by difficulty falling asleep, staying asleep, or both, despite having the opportunity for adequate sleep.
  • Functional dyspepsia: A chronic disorder of the upper digestive tract, characterized by recurrent pain or discomfort in the upper abdomen without any identifiable cause.
  • Hyperemesis gravidarum: A severe form of nausea and vomiting during pregnancy that can lead to dehydration, weight loss, and electrolyte imbalances.
  • Total Sleep Time (TST): The total amount of time spent asleep during a sleep period, often measured in clinical trials as an outcome for sleep-related studies.
  • Sleep Latency (SL): The length of time it takes to fall asleep after going to bed, often used as a measure of sleep quality in sleep studies.
  • Wake After Sleep Onset (WASO): The amount of time spent awake after initially falling asleep and before final awakening, used to assess sleep quality and continuity.
  • Adverse Event (AE): Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug or treatment being studied.

References

  1. https://clinicaltrials.gov/study/NCT00960830
  2. https://clinicaltrials.gov/study/NCT00610675
  3. https://clinicaltrials.gov/study/NCT01240096
  4. https://clinicaltrials.gov/study/NCT01601002
  5. https://clinicaltrials.gov/study/NCT01867775
  6. https://clinicaltrials.gov/study/NCT00878540
  7. https://clinicaltrials.gov/study/NCT00832520
  8. https://clinicaltrials.gov/study/NCT05452174
  9. https://clinicaltrials.gov/study/NCT00798395